The results of the TB-CHAMP trial were recently published. They showed that prophylactic levofloxacin can significantly reduce the risk of contracting MDR-TB in children younger than 5 who had a household exposure. This is one of the first successful trials for prevention of MDR-TB. Read more here.
top of page
Recent Posts
See AllThis month, the Indian Patent Office denied the last of the three Janssen patent extension applications for bedaquiline. While TB...
10
The Institute of Tropical Medicine has announced two initiatives to honor the legacy of Armand Van Deun: a new meeting room in his name...
420
The positive EndTB-Q trial results were shared at the Union conference. They showed that a BCDL regimen is successful in treating less...
190
bottom of page